A recently published preclinical study using personalized ultra-fractionated stereotactic adaptive radiotherapy (PULSAR) in combination with α-PD-L1 demonstrated that spacing radiation fractions 10 days apart would achieve better tumor control and immunological memory in “cold” tumors in comparison to traditional daily fractions (40). Here, CD274 is linked to neoplasm.